The Pakistan Medical Association (PMA) has expressed serious concerns over the shortage of life-saving medicines and other drugs. The association has requested the government to ease the process of opening letters of credit (LCs) for drug manufacturing companies. “Failing to open letters of credit (LC) for import of raw material would result in an acute shortage of medicine,” reads the official statement
Shortage of Life-saving Medicines to Exacerbate the Problems
According to the data, the production of 1,300 medications has been halted, and the numbers are expected to increase to 2,500 in the coming days as other companies are also expected to discontinue drug manufacturing due to inflation and raw material limitations. In this regard, the PMA has urged the government to take prompt and decisive action to prevent the already deteriorating situation and safeguard citizens’ lives.
PMA said that the manufacturers’ problems have worsened, and patients and their families are facing serious challenges due to the unavailability of life-saving medicines. PMA further added that the healthcare system is already in turmoil, and a shortage of pharmaceuticals would exacerbate the problem. The impact could be felt by the families who are economically disadvantaged and are expected to suffer the most if adequate measures are not implemented soon.
Also read: SBP Prioritize the Release of Edible Oil LCs to Avoid Shortage in Ramzan